Big Gain For Cleveland BioLabs, Inc.
Thu, Jan 30, 2020 at 05:30 PM
Cleveland BioLabs, Inc. (CBLI:NASDAQ) soared at $3.15, representing a gain of 41.3%. The stock got featured on our News Catalysts scanner on Tue 28 Jan 20 at 11:16 AM in the 'BIOTECH' category. From Wed 08 Jan 20, the stock recorded 57.14% Up Days and 46.67% Green Days
The stock spiked on Mon 27 Jan 20 at $4.9 with a volume of 14M+.
About Cleveland BioLabs, Inc. (CBLI:NASDAQ)
Cleveland BioLabs Inc is a biopharmaceutical company developing novel approaches to activate immune system & address medical needs. Its proprietary platform of toll-like immune receptor activators are used in radiation, oncology immunotherapy & vaccine.
Top 10 Gainers:
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 41.26%
- Sintx Technologies, Inc. (SINT:NASDAQ), 41.1%
- Advaxis, Inc. (ADXS:NASDAQ), 33.54%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 29.65%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 27.56%
- NanoViricides, Inc. (NNVC:NYSEMKT), 26.58%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 20.87%
- Lianluo Smart Limited (LLIT:NASDAQ), 20.83%
- Miragen Therapeutics, Inc. (MGEN:NASDAQ), 20.71%
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 20.4%